Research ArticleHIV

Immune perturbations in HIV-1–infected individuals who make broadly neutralizing antibodies

See allHide authors and affiliations

Science Immunology  29 Jul 2016:
Vol. 1, Issue 1, pp. aag0851
DOI: 10.1126/sciimmunol.aag0851

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Setting the stage for HIV vaccines

Some HIV-infected individuals produce antibodies that can target multiple HIV strains—broadly neutralizing antibodies. Moody et al. now compare HIV-infected individuals who produce these antibodies with those who do not. They find that broadly neutralizing antibody production associates with particular immune traits, including a higher frequency of autoantibodies, fewer regulatory T cells, and more circulating memory T follicular helper cells. Vaccine protocols that can mimic these immune perturbations may therefore promote induction of broadly neutralizing antibodies and lead to a more successful immune response to HIV.


Induction of broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development. bnAbs occur in some HIV-1–infected individuals and frequently have characteristics of autoantibodies. We have studied cohorts of HIV-1–infected individuals who made bnAbs and compared them with those who did not do so, and determined immune traits associated with the ability to produce bnAbs. HIV-1–infected individuals with bnAbs had a higher frequency of blood autoantibodies, a lower frequency of regulatory CD4+ T cells, a higher frequency of circulating memory T follicular helper CD4+ cells, and a higher T regulatory cell level of programmed cell death–1 expression compared with HIV-1–infected individuals without bnAbs. Thus, induction of HIV-1 bnAbs may require vaccination regimens that transiently mimic immunologic perturbations in HIV-1–infected individuals.

View Full Text

Stay Connected to Science Immunology